Thursday, July 29, 2010
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Peter Duncan
Director of Business Development
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: IT & Business Strategy
IT & Business Strategy
The IT antidote
The latest IT support tools are proving invaluable to the pharma industry
No Comments
Taxonomies enhance pharmaceutical content intelligence
By Michael Hoey, CEO, Intellisophic
No Comments
Business process excellence ? art or science?
Are pharmaceutical companies ready to face the challenges that are brewing up?
No Comments
Driving on the fast track to market
NPG speaks to Roger Gould about ROI from quality systems
No Comments
Appliance of science
NGP speaks to Lisa Ensign Netregulus Director of Study and Biostatistical Solutions about the importance of having the right applications
No Comments
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.